Literature DB >> 2751994

Electrostatic interactions in wild-type and mutant recombinant human myoglobins.

R Varadarajan1, D G Lambright, S G Boxer.   

Abstract

Residue Val68 in human myoglobin has been replaced by Asn, Asp, and Glu with site-directed mutagenesis. Purified proteins were characterized by isoelectric focusing and by absorption, CD, and NMR spectroscopy. These studies demonstrated that Mb is able to tolerate substitution of the buried hydrophobic residue Val68 by Asn, Asp, and Glu. In the metaquo derivatives of the Glu and Asp mutants, the negative charge at residue 68 is stabilized by a favorable Coulombic interaction with the heme iron. In the absence of this interaction, as in the metcyano and ferrous deoxy derivatives, the relatively nonpolar protein interior cannot stabilize an isolated buried negative charge, and the carboxylate is either protonated or stabilized via a salt bridge with the nearby distal histidine. Hence in the Asp and Glu mutant proteins, both reduction and cyanide binding are accompanied by proton uptake by the protein. The apoproteins were prepared and reconstituted with the chlorophyll derivative zinc pyrochlorophyllide a. Absorption and fluorescence spectra were quite similar for wild-type and all mutant proteins reconstituted with this derivative. These results do not support the point charge model for the red shifts observed in the spectra of chlorophylls associated with photosynthetic proteins. From the pH dependence of the absorption spectrum of zinc pyrochlorophyllide a in the Glu mutant, the apparent pKa of the buried glutamate residue was estimated to be 8.9. This increase of 4.4 pH units, over the value for Glu in aqueous solution, provides a measure of the polarity of the protein interior.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2751994     DOI: 10.1021/bi00435a022

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Ligand migration in human myoglobin: steric effects of isoleucine 107(G8) on O(2) and CO binding.

Authors:  H Ishikawa; T Uchida; S Takahashi; K Ishimori; I Morishima
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

Review 2.  Myoglobin: the hydrogen atom of biology and a paradigm of complexity.

Authors:  H Frauenfelder; B H McMahon; P W Fenimore
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-14       Impact factor: 11.205

3.  Mutagenesis-based definitions and probes of residue burial in proteins.

Authors:  Kanika Bajaj; Purbani Chakrabarti; Raghavan Varadarajan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-26       Impact factor: 11.205

4.  Mechanisms of tryptophan fluorescence shifts in proteins.

Authors:  J T Vivian; P R Callis
Journal:  Biophys J       Date:  2001-05       Impact factor: 4.033

5.  A procedure for the prediction of temperature-sensitive mutants of a globular protein based solely on the amino acid sequence.

Authors:  R Varadarajan; H A Nagarajaram; C Ramakrishnan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

6.  Incorporating protein conformational flexibility into the calculation of pH-dependent protein properties.

Authors:  E G Alexov; M R Gunner
Journal:  Biophys J       Date:  1997-05       Impact factor: 4.033

7.  Perturbations of the distal heme pocket in human myoglobin mutants probed by infrared spectroscopy of bound CO: correlation with ligand binding kinetics.

Authors:  S Balasubramanian; D G Lambright; S G Boxer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

8.  Do salt bridges stabilize proteins? A continuum electrostatic analysis.

Authors:  Z S Hendsch; B Tidor
Journal:  Protein Sci       Date:  1994-02       Impact factor: 6.725

Review 9.  Electric Fields and Enzyme Catalysis.

Authors:  Stephen D Fried; Steven G Boxer
Journal:  Annu Rev Biochem       Date:  2017-03-24       Impact factor: 23.643

Review 10.  Myoglobin strikes back.

Authors:  Maurizio Brunori
Journal:  Protein Sci       Date:  2010-02       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.